Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Atmar

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Uncommon(ly considered) manifestations of infection with rhinovirus, agent of the common coldRobert L Atmar
Food and Environmental Virology|September 4, 2010
Noroviruses - State of the ArtRobert L Atmar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2021
Birth Cohort Studies: Toward Understanding Protective Immunity to Human NorovirusesRobert L Atmar, Sasirekha Ramani
Antimicrobial Agents and Chemotherapy|July 21, 2022
New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19Robert L Atmar, Natalie Finch
Current Opinion in Infectious Diseases|May 21, 2019
Norovirus in health care and implications for the immunocompromised hostPearlie P Chong, Robert L Atmar
Current Topics in Microbiology and Immunology|September 22, 2009
Adjuvants for pandemic influenza vaccinesRobert L Atmar, Wendy A Keitel
Current Topics in Microbiology and Immunology|September 22, 2009
Vaccines for pandemic influenza: summary of recent clinical trialsWendy A Keitel, Robert L Atmar
The Journal of Infectious Diseases|October 31, 2019
Searching for Improved Flu Vaccines-The Time Is NowRobert L Atmar, Wendy A Keitel
The Journal of Infectious Diseases|October 31, 2015
Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?Robert L Atmar, Wendy A Keitel
Clinical Microbiology Newsletter|April 28, 2020
Nonculturable agents of viral gastroenteritisRobert L Atmar, Mary K Estes
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2005
Uncommon(ly considered) manifestations of infection with rhinovirus, agent of the common coldRobert L Atmar
Food and Environmental Virology|September 4, 2010
Noroviruses - State of the ArtRobert L Atmar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 27, 2021
Birth Cohort Studies: Toward Understanding Protective Immunity to Human NorovirusesRobert L Atmar, Sasirekha Ramani
Antimicrobial Agents and Chemotherapy|July 21, 2022
New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19Robert L Atmar, Natalie Finch
Current Opinion in Infectious Diseases|May 21, 2019
Norovirus in health care and implications for the immunocompromised hostPearlie P Chong, Robert L Atmar
Current Topics in Microbiology and Immunology|September 22, 2009
Adjuvants for pandemic influenza vaccinesRobert L Atmar, Wendy A Keitel
Current Topics in Microbiology and Immunology|September 22, 2009
Vaccines for pandemic influenza: summary of recent clinical trialsWendy A Keitel, Robert L Atmar
The Journal of Infectious Diseases|October 31, 2019
Searching for Improved Flu Vaccines-The Time Is NowRobert L Atmar, Wendy A Keitel
The Journal of Infectious Diseases|October 31, 2015
Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?Robert L Atmar, Wendy A Keitel
Clinical Microbiology Newsletter|April 28, 2020
Nonculturable agents of viral gastroenteritisRobert L Atmar, Mary K Estes
Pageof 27